Specifically, pathway analysis revealed that miR‐7704, can inhibit targets, including TSC1/2, which is a negative regulator of mTOR1 to promote cell growth,33, 34, 35 and SFN or stratifin factor, which is associated with cancer treatment resistance and PI3K/AKT signaling.38 Here, AKT1 is linked to cancer.